Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine - Yahoo Finance

Bavarian Nordic Receives Swissmedic Approval for Chikungunya Vaccine  Yahoo Finance

Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced heari...

Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children  PR Newswire

DINAMIQS receives Swissmedic license for viral vector manufacturing and testing - VC Magazin

DINAMIQS receives Swissmedic license for viral vector manufacturing and testing  VC Magazin

Santhera Receives Swissmedic Approval of AGAMREE® - GlobeNewswire

Santhera Receives Swissmedic Approval of AGAMREE®  GlobeNewswire

Swissmedic plans job cuts amid mounting financial pressures - SWI swissinfo.ch

Swissmedic plans job cuts amid mounting financial pressures  SWI swissinfo.ch

Agency for Therapeutic Products: Swissmedic to cut around 45 full-time positions within two years...

Agency for Therapeutic Products: Swissmedic to cut around 45 full-time positions within two years | blue News  blue News

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein...

Lonza Receives Swissmedic Approval for Highly Potent Biologics Drug Product Filling Line in Stein (CH)  the-scientist.com

Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products - Swissmedic

Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products  Swissmedic

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations ...

Euro Roundup: Swissmedic pilots fast-track procedure to accelerate clinical trial authorizations  RAPS.org

Swissmedic approves first malaria treatment for infants - drugdiscoverytrends.com

Swissmedic approves first malaria treatment for infants  drugdiscoverytrends.com

Swissmedic approves IFINWIL for children with high-risk neuroblastoma - Pharmaceutical Technology

Swissmedic approves IFINWIL for children with high-risk neuroblastoma  Pharmaceutical Technology

Switzerland Mutual Recognition Agreement - fda.gov

Switzerland Mutual Recognition Agreement  fda.gov

Swissmedic Accepts Marketing Authorization Application for Piflufolastat (18F) for Prostate Cance...

Swissmedic Accepts Marketing Authorization Application for Piflufolastat (18F) for Prostate Cancer  OncLive

Swissmedic grants manufacturing license to DINAMIQS for viral vector production - BioProcess Inte...

Swissmedic grants manufacturing license to DINAMIQS for viral vector production  BioProcess International

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (...

Swissmedic approves IFINWIL® (eflornithine) for children diagnosed with high-risk neuroblastoma (HRNB)  PR Newswire

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility ...

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland  Biogen

Swiss regulator warns against dangerous weight loss products - SWI swissinfo.ch

Swiss regulator warns against dangerous weight loss products  SWI swissinfo.ch

Swissmedic approves Orchard’s gene therapy for early-onset MLD - Pharmaceutical Technology

Swissmedic approves Orchard’s gene therapy for early-onset MLD  Pharmaceutical Technology

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution -...

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution  Swissmedic

Navigating the complexity: reflections on the development of perioperative cancer treatments - Th...

Navigating the complexity: reflections on the development of perioperative cancer treatments  The Lancet

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebet...

KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema  BioSpace

"Swissmedic 4.0" digital initiative concludes - Swissmedic

"Swissmedic 4.0" digital initiative concludes  Swissmedic

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeu...

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics  Greater Geneva Bern area

Santhera Announces Acceptance by Swissmedic of Marketing - GlobeNewswire

Santhera Announces Acceptance by Swissmedic of Marketing  GlobeNewswire

Novartis given green light for infant anti-malaria drug - SWI swissinfo.ch

Novartis given green light for infant anti-malaria drug  SWI swissinfo.ch

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic - Reuters

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic  Reuters

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine - Reuters

Pfizer applies to Swissmedic for authorisation of another COVID-19 vaccine  Reuters

First malaria treatment for newborn babies approved for use - The Washington Post

First malaria treatment for newborn babies approved for use  The Washington Post

Siegfried’s DINAMIQS Wins Swissmedic License, Expanding Viral Vector CDMO Capabilities - TipRanks

Siegfried’s DINAMIQS Wins Swissmedic License, Expanding Viral Vector CDMO Capabilities  TipRanks

Swiss Approve 1st Booster For Variants - Health Policy Watch

Swiss Approve 1st Booster For Variants  Health Policy Watch

Product groups without an intended medical purpose - Swissmedic

Product groups without an intended medical purpose  Swissmedic

Swissmedic and the Korean regulatory authority extend their cooperation in the area of therapeuti...

Swissmedic and the Korean regulatory authority extend their cooperation in the area of therapeutic products  Swissmedic

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulato...

“Revolving doors” with the pharmaceutical industry: a major source of influence on Swiss regulatory bodies?  Public Eye

Swissmedic approves QUVIVIQ (daridorexant) – a first-in-class treatment for chronic insomnia diso...

Swissmedic approves QUVIVIQ (daridorexant) – a first-in-class treatment for chronic insomnia disorder to improve both nighttime symptoms and daytime functioning  Yahoo Finance UK

Landmark listing of first three countries as WHO-Listed regulatory Authorities - World Health Org...

Landmark listing of first three countries as WHO-Listed regulatory Authorities  World Health Organization (WHO)

Committed to the next generation - Swissmedic

Committed to the next generation  Swissmedic

VMD and Swissmedic agree collaboration on veterinary medicinal products - GOV.UK

VMD and Swissmedic agree collaboration on veterinary medicinal products  GOV.UK

Switzerland’s bitter-sweet news for Alzheimer’s patients - SWI swissinfo.ch

Switzerland’s bitter-sweet news for Alzheimer’s patients  SWI swissinfo.ch

The handbook of medicinal product quality - Swissmedic

The handbook of medicinal product quality  Swissmedic

Swiss medicines regulator responds to Trump’s paracetamol claim - SWI swissinfo.ch

Swiss medicines regulator responds to Trump’s paracetamol claim  SWI swissinfo.ch

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News - ...

"Significant health risk": Swissmedic warns of dangerous fake weight loss syringes | blue News  blue News

Cannabis for medical purposes - Visible - Swissmedic

Cannabis for medical purposes - Visible  Swissmedic

What does the name Swissmedic mean to you? - Swissmedic

What does the name Swissmedic mean to you?  Swissmedic

Meet René: The IDF’s First Ever Swiss-Bedouin Medic - idf.il

Meet René: The IDF’s First Ever Swiss-Bedouin Medic  idf.il

Swiss Pharma Strength - PharmTech.com

Swiss Pharma Strength  PharmTech.com

MHRA and Swissmedic pledge greater collaboration - PMLiVE

MHRA and Swissmedic pledge greater collaboration  PMLiVE

How a clash with Roche exposed cracks in Swiss drug pricing system - SWI swissinfo.ch

How a clash with Roche exposed cracks in Swiss drug pricing system  SWI swissinfo.ch

CHUV introduces Switzerland's first gut-balancing medication - Greater Geneva Bern area

CHUV introduces Switzerland's first gut-balancing medication  Greater Geneva Bern area

Swiss regulator approves updated Covid-19 vaccine - SWI swissinfo.ch

Swiss regulator approves updated Covid-19 vaccine  SWI swissinfo.ch

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the...

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy  Newswire Canada

Swissmedic authorises new drug for respiratory disease - SWI swissinfo.ch

Swissmedic authorises new drug for respiratory disease  SWI swissinfo.ch

The Shady Business Of Experimental Stem Cell Treatments - Worldcrunch

The Shady Business Of Experimental Stem Cell Treatments  Worldcrunch

Swiss regulator and media clash over weight-loss drugs - SWI swissinfo.ch

Swiss regulator and media clash over weight-loss drugs  SWI swissinfo.ch

Interview with Raimund Bruhin, Executive Director of Swissmedic - Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic  Swissmedic

Improving international collaboration – MHRA and Swissmedic sign MoU - GOV.UK

Improving international collaboration – MHRA and Swissmedic sign MoU  GOV.UK

United Kingdom – Switzerland Regulatory Cooperation - GOV.UK

United Kingdom – Switzerland Regulatory Cooperation  GOV.UK

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections - SWI swissinfo.ch

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections  SWI swissinfo.ch

Health: Pharmacy slogan for corona vaccination violated advertising regulations | blue News - blu...

Health: Pharmacy slogan for corona vaccination violated advertising regulations | blue News  blue News

Switzerland approves first malaria drug for infants - The New Indian Express

Switzerland approves first malaria drug for infants  The New Indian Express

Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing - boerse.de

Siegfried DINAMIQS receives Swissmedic license for viral vector manufacturing  boerse.de

Medicine: First Alzheimer's drug approved in Switzerland | blue News - blue News

Medicine: First Alzheimer's drug approved in Switzerland | blue News  blue News

Seizures of illegally imported medicines triple in Switzerland - SWI swissinfo.ch

Seizures of illegally imported medicines triple in Switzerland  SWI swissinfo.ch

Emergency vaccine approval not legal option in Switzerland - SWI swissinfo.ch

Emergency vaccine approval not legal option in Switzerland  SWI swissinfo.ch

Swiss medicine regulator warns against purchase of fake Ozempic - SWI swissinfo.ch

Swiss medicine regulator warns against purchase of fake Ozempic  SWI swissinfo.ch

Asian medicines seek relief from strict regulations - SWI swissinfo.ch

Asian medicines seek relief from strict regulations  SWI swissinfo.ch

Swiss sound alarm over fake drug imports - SWI swissinfo.ch

Swiss sound alarm over fake drug imports  SWI swissinfo.ch

More drugs will soon be available without a prescription in Switzerland - lenews.ch

More drugs will soon be available without a prescription in Switzerland  lenews.ch